Physician

Amaraja Anil Kanitkar, MD

According to 2025 Medicare claims, Amaraja Kanitkar, MD (NPI: 1881912517) practices pulmonary disease in the Warren-Troy-Farmington Hills, MI market, with the plurality of this provider's patient population coming from Macomb, MI. This provider's primary affiliated billing organization is PULMONARY AND MEDICINE ASSOCIATES (NPI: 1417174319; TIN: 821099821) and primary practice location at 48093-6854. Kanitkar is affiliated with the CCA ACO LLC (ACO ID: A2198), participating under the MSSP model.

Kanitkar's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 379 traditional Medicare patients, billed 1,097 HCPCS/CPT codes, and received $121,537 in Medicare payments. The top billing code was 99291 (Critical care, first 30-74 minutes). Part D data shows 494 prescription claims across 99 beneficiaries totaling $196,784 in drug costs, led by Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter). DME data shows 196 claims. Open Payments data shows 2 records totaling $66. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $54,697 and ending at $121,537. Concurrently, Part D prescription costs have fallen sharply in recent years, from $42,882 to $196,784. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $751 and ending at $17,515.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	169	621	$54,697
2017	783	2,794	$202,207
2018	761	2,517	$172,404
2019	459	1,216	$79,225
2020	291	651	$71,695
2021	306	993	$120,097
2022	436	1,291	$127,860
2023	487	1,557	$167,001
2024	379	1,097	$121,537

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	39	263	$42,882
2016	51	164	$22,248
2017	163	593	$279,892
2018	260	1,160	$754,891
2019	207	1,358	$793,660
2020	101	434	$205,669
2021	36	57	$18,937
2022	32	97	$28,717
2023	86	396	$107,223
2024	99	494	$196,784

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	52	248	$8,294
2018	72	563	$34,865
2019	84	820	$56,345
2020	29	337	$24,691
2021	N/R	130	$6,755
2022	N/R	51	$2,861
2023	N/R	101	$4,547
2024	N/R	196	$8,843

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99291	Critical care, first 30-74 minutes	138	355	$171
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	80	81	$138
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	160	280	$95
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	60	116	$91
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	56	99	$62

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	96	4,680	$96,545
Breo Ellipta	Fluticasone/Vilanterol	12	600	$7,659
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	27	1,620	$6,012
Albuterol Sulfate Hfa	Albuterol Sulfate	92	2,984	$3,426
Ventolin Hfa	Albuterol Sulfate	35	944	$2,646

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	66	$5,214
E1392	Portable oxygen concentrator, rental	Y	N/R	46	$1,526
J7626	Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg	N	N/R	20	$982
Q0513	Pharmacy dispensing fee for inhalation drug(s); per 30 days	N	N/R	32	$776
J7620	Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme	N	N/R	18	$310

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	2	$66	Boehringer Ingelheim Pharmaceuticals, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Amaraja Anil Kanitkar, MD?

Tedicare shows public-source Medicare data for Amaraja Anil Kanitkar, MD (NPI 1881912517), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Amaraja Anil Kanitkar, MD have ACO affiliation data?

Amaraja Anil Kanitkar, MD is shown with ACO affiliation data for CCA ACO LLC (MSSP, ACO ID A2198).

What billing organization is linked to Amaraja Anil Kanitkar, MD?

Amaraja Anil Kanitkar, MD is linked to PULMONARY AND MEDICINE ASSOCIATES (billing NPI 1417174319) in the available physician profile data.

Does Amaraja Anil Kanitkar, MD have Open Payments data?

Amaraja Anil Kanitkar, MD has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.